SCRAP3y

The purpose of the data collection is to assess the safety of angioplasty procedures in the cardiology department of the hospital in la Rochelle. Consecutive cases over one year were enrolled.

Clinical and procedural data were collected at inclusion to describe the study population. One and three-year follow-up data were collected to determine the number of major adverse cardiac events (MACE) (all-cause death, non-fatal myocardial infarction, non-fatal stroke and revascularization of target lesion).

Categorical data were used for inclusion/exclusion criteria, gender, clinical history, clinical indication, procedural data, lesion data, type of follow up, treatment and MACE. Continuous data were collected for age, body mass index, biological data, radiation data, duration, diameter and length of treated lesions.

Clinical and procedural data were retrieved from CardioReport^TM (MediReport).

Follow-up data were obtained after patient phone call, consultation, or hospital admission.

Three databases are available:

- The patient database includes age, sex, body mass index, history, indication, treatment and MACE. Details on the variables are given in the patient readme file.

- The procedure database includes biological data, radiation data, procedure and scopy time length, use of specific procedure (scoring, rotablator, fractional flow reserve). Details on the variables are given in the Procedure legend file.

- The lesion database includes the location of treated lesions, presence or absence of in-stent restenosis, occlusion or bifurcation, type of material, material diameter and length, and the name of the material. Details on the variables are given in the lesion legend file.